Moleculin Biotech Inc (MBRX): $mbrx..$1.08...ask getting hammered eod....

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	0
Posts	63269
Boards Moderated	4
Alias Born	06/06/2012

TommyBoyTrader9460

Re: whytestocks post# 1095

Thursday, 04/18/2019 3:48:26 PM

Thursday, April 18, 2019 3:48:26 PM

$mbrx..$1.08...ask getting hammered eod..know what you own everyone...

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent MBRX News

Form 8-K - Current report • Edgar (US Regulatory) • 04/23/2026 12:25:26 PM
Moleculin’s Annamycin Extends Survival by More Than 60% in Metastatic Pancreatic Cancer Preclinical Models - Data Presented at AACR 2026 • GlobeNewswire Inc. • 04/23/2026 12:25:00 PM
Moleculin Announces Abstract Accepted for Poster Presentation at the 2026 ASCO Annual Meeting • GlobeNewswire Inc. • 04/21/2026 12:36:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 04/15/2026 03:40:38 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/15/2026 04:15:07 AM
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 04/14/2026 09:26:57 PM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/14/2026 08:56:35 PM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 03/27/2026 08:01:09 PM
Moleculin Hits 45 Subject Enrollment Milestone, Triggering Final Countdown to Mid-2026 MIRACLE Trial Data Readout • GlobeNewswire Inc. • 03/23/2026 12:31:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/23/2026 12:30:09 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/19/2026 12:45:15 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/19/2026 12:35:12 PM
Moleculin to Present at 38th Annual ROTH Conference • GlobeNewswire Inc. • 03/17/2026 01:05:00 PM
Moleculin Releases Next CEO Corner Segment Highlighting MIRACLE Study • GlobeNewswire Inc. • 03/11/2026 01:00:00 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/09/2026 07:58:05 PM
Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 02/27/2026 07:09:49 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2026 01:50:23 PM
Moleculin shares slide sharply after warrant exercise deal • IH Market News • 02/19/2026 03:46:31 PM
Moleculin Announces Exercise of Warrants for $8.3 Million Gross Proceeds • GlobeNewswire Inc. • 02/19/2026 01:39:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/18/2026 09:31:16 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/18/2026 01:20:16 PM
Moleculin MIRACLE Trial Delivers 40% Preliminary Blinded CRc Rate (n=30) • GlobeNewswire Inc. • 02/18/2026 01:20:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/17/2026 01:35:16 PM
Moleculin Announces Notice of Allowance for Japanese Patent Covering Annamycin • GlobeNewswire Inc. • 02/17/2026 01:35:00 PM
Moleculin Launches CEO Corner Platform to Share Strategic Insights • GlobeNewswire Inc. • 02/13/2026 01:32:00 PM

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Detailed Quote

Recent MBRX News

More MBRX News

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Recent MBRX News

Go Ad-Free